20102020
If you made any changes in Pure these will be visible here soon.

Research Output 2010 2020

Filter
Poster
2018

Proteomic comparison of clinical breast cancer samples, corresponding patient derived xenografts (PDX) and mammospheres reveal increased cholesterol biosynthesis as a key feature of cancer stem cells

Ehmsen, S., Pedersen, M. H., Arslanagic, A., Terp, M. G., Leth-Larsen, R., Ditzel, H., Hood, B. L. & Conrads, T. P., 4. May 2018.

Research output: Contribution to conference without publisher/journalPosterCommunication

2016

Dual epitope targeting of CD73 exhibits potent anti-cancer activity

Gammelgaard, O. L., Terp, M. G., Parren, P. W. H. I., Leth-Larsen, R. & Ditzel, H., 2016.

Research output: Contribution to conference without publisher/journalPosterResearch

2013

Set-up of Mouse Models for Nanodrug Testing

Hansen, P. L., Riedel, A., Schmidt, S., Terp, M. G., Trojnar, J. H., Schifter, S., Olsen, B. B., Thisgaard, H., Ditzel, H., Høilund-Carlsen, P. F. & Mollenhauer, J., 2013.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

2012

Identification of Markers Associated with Highly Aggressive Metastatic Phenotypes Using Quantitative Comparative Proteomics

Terp, M. G., Lund, R. R., Jensen, O. N., Leth-Larsen, R. & Ditzel, H., 29. Nov 2012.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

2011

Antibodies targeting human CD73 inhibit breast tumor growth

Terp, M. G., Fredberg, L., Lund, R. R., Skjødt, K., Ditzel, H. & Leth-Larsen, R., 9. Mar 2011.

Research output: Contribution to conference without publisher/journalPosterResearch

Construction of new cancer cell models for nanodrug discovery and testing

Hansen, P. L., Olsen, S. B., Terp, M. G., Schmidt, S., Riedel, A., Müller, C., Block, I., Christiansen, H., Ditzel, H. & Mollenhauer, J., 23. May 2011.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Heterogeneity within the cancer stem cell population as defined by CD44+/CD24low/- in breast cancer

Leth-Larsen, R., Terp, M. G., Christensen, A. G. L., Elias, D., Kühlwein, T., Jensen, O. N., Petersen, O. W. & Ditzel, H., 6. Mar 2011.

Research output: Contribution to conference without publisher/journalPosterResearch

Quantitative Proteome Analysis of Cancer Tissues using SILAC-labeled Proteins of Multiple Histogenic Origins

Lund, R. R., Terp, M. G., Jensen, O. N., Leth-Larsen, R. & Ditzel, H., 20. Jun 2011.

Research output: Contribution to conference without publisher/journalPosterResearch

The cancer-germline antigen SSX2 causes cell cycle arrest and DNA damage in cancer cells

Greve, K. B. V., Lindgreen, J., Terp, M. G., Schmidt, S., Mollenhauer, J., Ditzel, H. & Gjerstorff, M., Oct 2011. 1 p.

Research output: Contribution to conference without publisher/journalPosterResearch

2010

CD44 Variant Isoforms in Triple-Negative Breast Cancer

Leth-Larsen, R., Christensen, A. G. L., Terp, M. G., Hansen, H. V., Petersen, O. W. & Ditzel, H., 2010.

Research output: Contribution to conference without publisher/journalPosterResearch

Protein Profiling of Primary Tumors with Different Abilities to Establish Lung Metastases

Lund, R. R., Terp, M. G., Leth-Larsen, R., Jensen, O. N. & Ditzel, H., 2010.

Research output: Contribution to conference without publisher/journalPosterResearch